Onions prevent the progression of ovarian cancer.

Recently, Japanese researchers discovered that onionine A, a compound found in onions, has anti-cancer activity against ovarian tumors. This opens up new opportunities in the treatment of ovarian cancer patients.

According to the World Health Organization, epithelial ovarian cancer is the most common type of ovarian cancer today, with a five-year survival rate of approximately 40%. However, the majority of patients (80%) will experience recurrence after chemotherapy. This is why experts are searching for a more effective treatment.

Recently, researchers at Kamumoto University in Japan discovered a compound in onions called Onionine A. According to them, it possesses anti-ovarian cancer activity.

Research published in scientific reports shows that: “This compound reduces the progression of malignant ovarian tumors by interfering with the tumor-specific function of myeloid lineage cells.” Furthermore, experts also assert that: “Onionine A can improve the effectiveness of anticancer drugs by increasing their ability to inhibit tumor proliferation.”

In an experiment conducted on mice, experts showed that "ovarian tumors decreased and the mice's lifespan increased." They also concluded that "Onionine A, found in onions, could replace supplemental treatment for ovarian cancer patients." This has truly opened up treatment opportunities for ovarian cancer patients.

According to Dantri